Steris PLC (STE)
223.42
-5.75
(-2.51%)
USD |
NYSE |
May 28, 16:00
223.42
0.00 (0.00%)
After-Hours: 16:11
Steris Research and Development Expense (TTM): 105.92M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 105.92M |
| December 31, 2023 | 104.85M |
| September 30, 2023 | 104.45M |
| June 30, 2023 | 102.33M |
| March 31, 2023 | 101.58M |
| December 31, 2022 | 101.29M |
| September 30, 2022 | 100.60M |
| June 30, 2022 | 94.50M |
| March 31, 2022 | 87.94M |
| December 31, 2021 | 79.36M |
| September 30, 2021 | 70.98M |
| June 30, 2021 | 68.29M |
| March 31, 2021 | 66.33M |
| December 31, 2020 | 66.04M |
| September 30, 2020 | 66.09M |
| June 30, 2020 | 66.19M |
| March 31, 2020 | 65.55M |
| December 31, 2019 | 64.20M |
| September 30, 2019 | 62.88M |
| June 30, 2019 | 62.40M |
| March 31, 2019 | 63.04M |
| December 31, 2018 | 64.77M |
| September 30, 2018 | 64.80M |
| June 30, 2018 | 63.00M |
| March 31, 2018 | 60.78M |
| Date | Value |
|---|---|
| December 31, 2017 | 58.93M |
| September 30, 2017 | 58.33M |
| June 30, 2017 | 58.97M |
| March 31, 2017 | 59.40M |
| December 31, 2016 | 57.95M |
| September 30, 2016 | 57.69M |
| June 30, 2016 | 57.33M |
| March 31, 2016 | 56.66M |
| December 31, 2015 | 56.53M |
| September 30, 2015 | 56.74M |
| June 30, 2015 | 55.50M |
| March 31, 2015 | 54.14M |
| December 31, 2014 | 51.64M |
| September 30, 2014 | 48.68M |
| June 30, 2014 | 49.20M |
| March 31, 2014 | 48.64M |
| December 31, 2013 | 48.69M |
| September 30, 2013 | 47.52M |
| June 30, 2013 | 43.85M |
| March 31, 2013 | 41.30M |
| December 31, 2012 | 38.66M |
| September 30, 2012 | 37.45M |
| June 30, 2012 | 36.51M |
| March 31, 2012 | 35.95M |
| December 31, 2011 | 36.76M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
62.40M
Minimum
Jun 2019
105.92M
Maximum
Mar 2024
82.09M
Average
75.17M
Median
Research and Development Expense (TTM) Benchmarks
| Edwards Lifesciences Corp | 1.096B |
| ResMed Inc | 304.81M |
| Align Technology Inc | 351.24M |
| ThermoGenesis Holdings Inc | 1.189M |
| Nutriband Inc | 1.960M |